Cigarette Smoking Behavior

3

Review clinical trials related to Cigarette Smoking Behavior. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Generalized and Domain-Specific Episodic Thinking for Smoking Cessation

Cigarette smoking remains common, particularly in rural areas, despite ample evidence that smoking causes cancer and respiratory disease. Successful smoking cessation yields the majority of its health benefits (e.g., avoidance of lung cancer) after years of sustained behavioral change; however, people who smoke cigarettes tend to show elevated rates of delay discounting (i.e., devaluation of delayed outcomes) and a bias for immediate gratification. The overall goal of this project is to develop different versions of an episodic future thinking intervention (i.e., visualization of the future) and test their feasibility and efficacy for smoking cessation in rural and urban populations.

Participants needed: 134
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Virginia Polytechnic Institute and State UniversityUpdated: Oct 13, 2026Locations: 1
Eligibility criteria

smoked cigarettes daily for the last 30 days; [+2]

prior diagnosis with a smoking-related illness (e.g., respiratory disease); [+3]

Status: Recruiting

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

This study aims to investigate harm-reduction sampling in a choice format versus medicinal nicotine sampling on smoking behavior, identify mechanisms of sampling's effects, and explore moderators of these effects among a national sample of people unmotivated to quit smoking. Participants will be randomized 2:1 to choose one of two harm-reduction products (ECIG, ONP) versus a medicinal nicotine control condition (nicotine patch + lozenge, NPL), receive a 4-week starter product regimen, and then be followed for 6 months to assess use behavior.

Participants needed: 472
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Abramson Cancer Center at Penn MedicineUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Able to communicate fluently in English (i.e., speaking, writing, and reading) [+5]

Regular use of nicotine-containing products other than cigarettes (e.g., chewing... [+11]

Status: Recruiting

Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study

The goal of this clinical trial is to learn about the role of flavored on!® nicotine pouch products (the research products), an oral tobacco-leaf-free product, in the replacement of cigarettes with the use of the research products among adults who smoke cigarettes. The main question it aims to answer is whether flavored (vs. non-flavored) research products generate greater reduction of cigarette smoking among adults who smoke cigarettes. Participants will be provided with research products to use for 6 weeks. Researchers will compare the reduction in cigarette smoking between participants with access to a complete flavor profile of research products and participants with access to only the Original (non-flavored) variety of research product to see if reduction in cigarette smoking is greater among those with access to flavored research products.

Participants needed: 400
Trial details
Age: 22-65Biological sex: AllType: InterventionalSponsor: Altria Client Services LLCUpdated: Jul 11, 2024Locations: 1
Eligibility criteria

Has signed the Informed Consent Form (ICF) and is able to read and understand th... [+6]

Participant enrollment numbers met (in sub-group or entire study). [+17]